During the past decade, Georgetown University Hospital - Dept of Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgetown University Hospital - Dept of Neurology" #1 sponsor was "Enterin Inc." with 2 trials, followed by "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "National Institute on Aging (NIA)" with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgetown University Hospital - Dept of Neurology" #1 collaborator was "DSM Nutritional Products, Inc." with 1 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Georgetown University Hospital - Dept of Neurology" are "Alzheimer's Disease" (2 trials), "Constipation" (2 trials), "Age-Related Memory Disorders" (1 trials), "Alzheimer Disease" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Georgetown University Hospital - Dept of Neurology" in a lesser frequency.

Most popular intervention types in "Georgetown University Hospital - Dept of Neurology" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "ACC-001 10 μg/ QS-21 50 μg" (1 trials), "ACC-001 3 μg/ QS-21 50 μg" (1 trials), "Active Investigational Treatment ENT-01" (1 trials) and "DHA (Docosahexaenoic Acid)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgetown University Hospital - Dept of Neurology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Georgetown University Hospital - Dept of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Georgetown University Hospital - Dept of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Georgetown University Hospital - Dept of Neurology, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".